由杂合H223R-PTH1R突变所致Jansen干骺端软骨发育不良伴或不伴明显高钙血症
本文报告一位母亲及其两个儿子均携带杂合H223R-PTH1R突变并具有Jansen干骺端软骨发育不良(JMC)影像学表现,但仅两名患儿出现明显高钙血症和PTH水平受抑,38岁母亲从未出现明显高钙血症。研究提示即使由该相对常见突变所致,JMC也并非总伴明显高钙血症,不同年龄的影像学表现有助于早期诊断。
要点
- 三名携带杂合H223R-PTH1R突变者均有JMC影像学证据,但仅两名患儿出现明显高钙血症和PTH受抑。
- 38岁母亲从未出现明显高钙血症,直至两名儿子分别于28个月和40天龄确诊JMC后才被诊断。
- JMC即使由相对常见的H223R突变所致,也并非总伴明显高钙血症。
核心结论
- H223R突变通常伴严重高钙血症和低/正常PTH水平,但本文所见表明JMC并非总出现明显高钙血症,即使由该相对常见突变所致,这与其它组成性活性较低的PTH1R突变观察结果相似。
研究设计与样本
- 本文报告一名母亲及其两个儿子共三名具有JMC影像学证据的患者,采用Sanger测序和PCR扩增基因组DNA的内切酶(SphI)消化寻找H223R-PTH1R突变。
主要发现
- 三名受累个体均检出杂合H223R突变,但仅两名患儿出现明显高钙血症和PTH水平受抑。
- 38岁母亲从未出现明显高钙血症,直至两名儿子分别于28个月和40天龄确诊JMC后才被诊断。
- 本文展示的不同年龄影像学表现有助于诊断其他疑似JMC的婴幼儿。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Jansen's metaphyseal chondrodysplasia (JMC) is a rare skeletal dysplasia characterized by abnormal endochondral bone formation and typically severe hypercalcemia despite normal/low levels of PTH. Five different heterozygous activating PTH/PTHrP receptor (PTH1R) mutations that change one of three different amino acid residues are known to cause JMC. OBJECTIVES: Establishing the diagnosis of JMC during infancy or early childhood can be challenging, especially in the absence of family history and/or overt hypercalcemia. We therefore sought to provide radiographic findings supporting this diagnosis early in life. PATIENTS AND METHODS: Three patients, a mother and her two sons, had radiographic evidence for JMC. However, obvious hypercalcemia and suppressed PTH levels were encountered only in both affected children. Sanger sequencing and endonuclease (SphI) digestion of PCR-amplified genomic DNA were performed to search for the H223R-PTH1R mutation. RESULTS: The heterozygous H223R mutation was identified in all three affected individuals. Surprisingly, however, the now 38-year-old mother was never overtly hypercalcemic and was therefore not diagnosed until her sons were found to be affected by JMC at the ages of 28 months and 40 days, respectively. The presented radiographic findings at different ages will help diagnose other infants/toddlers suspected of having JMC. CONCLUSION: The H223R mutation is typically associated with profound hypercalcemia despite low/normal PTH levels. However, the findings presented herein show that overt hypercalcemia is not always encountered in JMC, even if caused by this relatively frequent mutation, which is similar to observations with other PTH1R mutations that show less constitutive activity.
引用
- Nampoothiri S, Fernández-Rebollo E, Yesodharan D, et al. Jansen Metaphyseal Chondrodysplasia due to Heterozygous H223R-PTH1R Mutations With or Without Overt Hypercalcemia. J Clin Endocrinol Metab. 2016. PMID: 27410178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。